Try our Advanced Search for more refined results

FTC Says 3rd Circ. Ruling Can't Help AbbVie In AndroGel Case

By Matthew Perlman ( September 8, 2020, 6:02 PM EDT) -- The Federal Trade Commission has urged the Third Circuit to ignore AbbVie Inc. 's assertion that a recent ruling involving alleged abuse of the litigation process supports the company's bid to evade claims that it used sham lawsuits to delay generic competition for its AndroGel testosterone treatment. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Subscribers Only

Nature of Suit

Subscribers Only

Judge

Subscribers Only

Date Filed

Subscribers Only

Law Firms

Companies

Government Agencies